A Case of Rituximab-Induced Necrotizing Fasciitis and a Review of the Literature.

Authors

Abdullateef Abdulkareem, Department of Internal Medicine, Reading Hospital and Medical Center, West Reading, Pennsylvania, USA.Follow
Ryan S D'Souza, Department of Medicine, Reading Hospital, West Reading, PA, USA, Department of Anesthesiology, Mayo Clinic Hospital, Rochester, MN, USA
Anthony Donato, Department of Medicine, Reading Hospital, West Reading, PA, USA
Oluwaseun Shogbesan, Department of Medicine, Reading Hospital, West Reading, PA, USA

Document Type

Article

Publication Date

9-26-2017

Abstract

Necrotizing fasciitis is a fulminant soft tissue infection characterized by rapid progression and high mortality. Rituximab is a generally well-tolerated immunosuppresive medication used for B-cell malignancies and some rheumatological disorders. We report a case of a 69-year-old male with chronic lymphocytic leukemia who suffered necrotizing fasciitis of his left lower extremity secondary to

Publication Title

Case Rep Hematol

Volume

2017

Recommended Citation

Abdulkareem, A., D'Souza, R., Donato, A., & Shogbesan, O. (2017). A Case of Rituximab-Induced Necrotizing Fasciitis and a Review of the Literature.. Case Rep Hematol, 2017 https://doi.org/10.1155/2017/6971027